Tome Bio is in the process of developing a gene therapy for patients with CBS Deficiency Homocystinuria.
For the most up-to-date news on their enzyme replacement, please visit their website: Click here
Tome Bio is in the process of developing a gene therapy for patients with CBS Deficiency Homocystinuria.
For the most up-to-date news on their enzyme replacement, please visit their website: Click here
© 2016 Enigma Theme|Theme Developed By Weblizar Themes